July 15, 2016，& ldquo; 2015 China Pharmaceutical Industry Top 100 List & RDQUO;，This selection activity was officially launched in January 2016，The Selection Committee conducted a five -month -old dense data survey for companies registered in China。This released & ldquo; China Pharmaceutical Industry Top 100 List & RDQUO;，Pharmaceutical machinery and animal drug revenue account for more than 90%of manufacturing companies are not within the scope of statistics，At the same time, multinational pharmaceutical companies will not be included in this ranking in Chinese subsidiaries，Some enterprises have not included it in this ranking。

 

  The proportion of the chemical drug industry is reduced

 

  Five Pharmaceutical Industries of China Pharmaceutical Industry (Chemical Raw Material Industry、Chemical Drug Preparation Industry、Biological Preparation Industry、Chinese medicine industry and traditional Chinese medicine decoction industry) Sales revenue from 3 in 2005,63.3 billion yuan increased to 22 in Stake Sports Betting2015,Stake Sports Betting56.4 billion yuan (monitored by the South)，increased by 6.2 times。Where，The proportion of chemical raw materials and chemical drug preparations is reduced，reduced from 31.7%and 31.3%to 20.7%and 30.8%，The proportion of chemicals and medicines is reduced significantly，Chinese medicine、The proportion of biological preparations and Chinese medicine tablets increases，From 25.2%、8.7%and 3.1%increase to 27.6%、13.5%and 7.5%。

 

  In terms of profit，In 2005, the total profit of the five major sub -industries in my country's pharmaceutical industry was 31 billion yuan，The total profit in 2015 has reached 229.3 billion yuan (monitoring of the South)，increased by 7.4 times。Where，The proportion of the profit of chemicals and medicines and the profit industry of China Pharmaceuticals is reduced，reduced from 20.9%and 31.1%to 15.1%and 28.3%，The proportion of the remaining three sub -industries increases。

 

  Top 100 Top 100 continues to expand

 

  The scale of the top 100 pharmaceutical industry in my country is continuously expanded，1 from 2005,45.1 billion yuan increased to 10 in 2015,45.8 billion yuan，Expanded 6.2 times。2015，The top 100 growth rate of the Chinese pharmaceutical industry is 10.8%。

 

 

  The distribution of the scale interval of the list of enterprises is: 55%of the companies in the top 100 drugs in 2005 are concentrated below 1 billion yuan，The scale of the top 100 drugs in 2015 is mostly concentrated in the range of 2 billion to 5 billion yuan (42)。In 2010, 5 companies broke through the 10 billion yuan mark for the first time，By 2015, 12 have already been available，Among them, there are 5 more than 20 billion yuan; 23 companies with 5 billion to 10 billion yuan。Pharmaceutical Top 100 Enterprises expand the momentum very rapid。

 

  The threshold for the top 100 exceeded 1.3 billion yuan

 

 

  2005，The threshold for the finalists of the top 100 pharmaceuticals in My stake betting appstake online sports bettingChina is only 480 million yuan，Then go year by year，2013 due to the selection rules，The list does not contain foreign companies，The threshold dropped to 930 million yuan，In 2015, the threshold for the finalists of the Fortune Top 100 reached 1.30 billion yuan，increased by 12.0%compared to 2014，This also reflects the overall growth of mainstream domestic pharmaceutical companies。Where，Small and medium -sized enterprises explain this feature from the rapid leap from the 100th position，For example, Lu Kaochen Pharmaceutical, the 100th in 2008, jumped to 82 -bit，The 100th Zhejiang Huahai Pharmaceuticals in 2010 jumped to 49 -bit in 2015。

 

  The proportion of the eastern region is reduced

 

 

  The number of companies in the top 100 companies (divided according to economic geography)，In 2015, there were 64 top 100 companies in the eastern region，A decrease of 9 from 2005。Among them, the number of Jiangsu Province was the largest in 2005 (15)，In 2015, the most in Guangdong and Shandong Province (11th)。and China、The number of top 100 companies in the Western region in the Western region was 23 and 13 respectively。

 

  The top 100 enterprises account for the industry (data is the sales proportion of the five major sub -industries in the sales of the top 100 enterprises in each province)，2005东、Middle、The western parts occupy 28.5%、6.8%and 3.7%，2015 is 25.3%、7.6%and 4.0%，Where，The top 100 companies in Shanghai account for the highest proportion of the industry，up to 5.5%。

 

  The concentration of the top 100 has gradually increased

 

 

  2015，The top 100 concentration of the Chinese pharmaceutical industry is 46.3%，increased by 7.4 percentage points from 2005，increased by 0.5 percentage points from 2014。Although this still has a certain gap with the target of the top 100%of the top 100%of the top 100%of the pharmaceutical industry，But with the acceleration of industrial stake sports betting appstake sports betting appintegration，In particular, the consistency evaluation of generic drugs and the two -vote system drive the industry's large shuffle，Strengthening the reorganization of corporate mergers and acquisitions，I believe that the concentration of the top 100 pharmaceutical industry will be further improved in 2016。

 

  Leading Group，The top ten concentration of the top ten drug industry in 2015 reached 21.1%，About 50%of the top 100 companies，The concentration of the top 20 of the list reached 28.3%。

 

  The industry status of Chinese medicine enterprises increases

 

 

  Among the top 100 drug -making companies in 2015，There are 53 chemical drug companies，39 Chinese medicine companies，4 biological products，Compared with 2005 and 2010，The number of chemicals companies has decreased，The number of traditional Chinese medicine companies and biological products has increased。From the perspective of the corresponding industry status of the top 100 companies，Three types of industries are the highest in sales with the top 100 Chinese medicine companies，up to 45.8%; profit proportion of chemical drug industry、Chinese medicine industry and biological preparation industry account for 30.7%, respectively、39.1%and 6.3%。

 

  Some companies are far ahead

 

  2015，Pharmaceutical Five Sons Industry sales revenue growth and profit growth average levels are 9.6%and 10.7%，Some companies in the top 100 companies have far ahead of the industry average。Jiuzhitang's sales revenue in 2015，reaches 91%，A total of 6 companies' sales revenue increased by more than 50%。In terms of net interest rate growth, there are more than 100%of 5 companies。

 

  Since 2011, the number of listed companies in the top 100 pharmaceutical industry in my country exceeds 70，It has basically maintained a relatively stable state in recent years。2015，78 companies stake betting appamong the top 100 companies Stake Sports Bettingin pharmaceutical industry，1 increase in 2014。The subsidiaries of the consolidated scope of the listed company have exceeded 1100，up to 1150，The capital operation pace of the top 100 companies gradually accelerates。

 

  In the past ten years，The sales revenue of listed companies in the top 100 companies increased year by year，2015 has reached 79.4%，increased by 29.3 percentage points from 2006。A total of 8 listed companies in the top ten，Sales revenue accounts for nearly 40%。